AI Credit Rating 4/A - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer) Score: 74

4/A - INTERCEPT PHARMACEUTICALS, INC. (0001270073) (Issuer) AI credit
rating value 74 Beta DRL value REG 40 Rational Demand Factor LD
3384.7925999999998 AI check at Sat Aug 24 2019 02:17:31 GMT+0200 (EET)
by AC Investment Inc. AI Terminal Reason: (n+7) Expectation Beta Code:
4623 Rating AI Process rely on primary sources of information: Sec
Filings, Financial Statements, Return on Revenue, EBITDA Margin,
Debt-To-Income Ratio, Price-to-Earnings Ratio, PEG Ratio,
Price-to-Sales Ratio, Dividend Payout Ratio, Return on Assets, Current
Ratio, Debt to Equity Ratio, Asset Turnover Ratio, Annual Reports,
Analyst Estimates Rating, Earnings, Stock Data, Risk and Credit
Reports, Search Volume Trends and Price Forecast Data. Take a look at
Machine Learning section for Financial Deep Reinforcement Learning.
We work across the world

From London to San Francisco, to our home base in (Saint Helier) Jersey, we’re looking for extraordinary and creative scientists to help us drive the field forward.

AC Investment Inc. currently does not act as an equities executing broker or route orders containing equities securities. If AC Invest’s business model were to change and it begins routing non-directed orders in NMS securities, it will comply with the disclosure requirement of Rule 606.

77 Massachusetts Avenue Cambridge, MA 02139 617-253-1000 pr@ademcetinkaya.com